Thomas P. Schnettler - 13 Dec 2022 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Director
Signature
/s/ Thomas P. Schnettler, by Brian McKelligon, as Attorney-in-Fact
Issuer symbol
AKYA
Transactions as of
13 Dec 2022
Net transactions value
-$925,782
Form type
4
Filing time
20 Dec 2022, 15:02:02 UTC
Previous filing
03 Jun 2022
Next filing
19 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKYA Common Stock Sale $925,782 -71,050 -2.5% $13.03 2,742,721 13 Dec 2022 Held by Piper Sandler Merchant Banking Fund II, L.P. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 PSC Capital Management II LLC is the general partner of Piper Sandler Merchant Banking Fund II, L.P. Piper Sandler Companies is the manager of PSC Capital Management II LLC. The reporting person is the Co-CEO of PSC Capital Management II LLC and disclaims beneficial ownership of the shares held by Piper Sandler Merchant Banking Fund II, L.P.